Schedule 13G ownership disclosure

SILO PHARMA INC COM

Security class unavailable · CUSIP: 82711P201

Event date: 2024-06-04

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
193,345
Percent of class
4.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001213900-24-052491
Form type
SC 13G
Filer
INTRACOASTAL CAPITAL, LLC
CIK
CIK 1646799
Filed
Jun 13, 2024
Reporting period
Jun 04, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub